Journal article

Is Nasal High Flow Inferior to Continuous Positive Airway Pressure for Neonates?

Kate A Hodgson, Brett J Manley, Peter G Davis

Clinics in Perinatology | W B SAUNDERS CO-ELSEVIER INC | Published : 2019


Nasal high-flow therapy (nHF) is increasingly used for neonates, with perceived benefits including reduced rates of nasal trauma and parent and nursing staff preference. Current evidence suggests that although nHF is a reasonable alternative for postextubation support of preterm infants, continuous positive airway pressure is a superior modality for primary support of respiratory distress syndrome. Minimal evidence exists for use of nHF in extremely preterm infants less than 28 weeks' gestation. Depending on clinician preference, units may still choose nHF in some settings, although careful choice of appropriate patients, and availability of rescue continuous positive airway pressure, is ess..

View full abstract